Generation of activated natural killer (A‐NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl‐positive targets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generation of activated natural killer (A‐NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl‐positive targets

Published:1996-05 Issue:2 Volume:93 Page:375-385
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Silla Lucia M. R.¹²,Pincus Steven M.³⁴⁵,Locker Joseph D.⁶⁵,Glover Janice⁶,Elder Elaine M.⁵,Donnenberg Albert D.³⁴⁵,Nardi N. B.¹²,Bryant John⁷⁵,Ball Edward D.³⁴⁵,Whiteside Theresa L.⁶⁸⁵

Affiliation:

1. Department of Internal Medicine,

2. Department of Genetics, Federal University of Rio Grande do Sul, Brazil

3. Departments of Hematology/Bone Marrow Transplantation

4. Medicine

5. Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, U.S.A.

6. Pathology

7. Mathematics and Biostatistics

8. Otolaryngology

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.1996.4991043.x

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy;Biomolecules;2022-05-27

2. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells;Frontiers in Immunology;2019-10-11

3. What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?;Hematology, Transfusion and Cell Therapy;2019-07

4. Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?;Critical Reviews in Oncology/Hematology;2014-02

5. Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia;International Journal of Hematology;2013-12-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3